PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026

Rhea-AI Summary

PAVmed (Nasdaq: LUCD) will host a First Quarter 2026 business update conference call and webcast on May 15, 2026 at 8:30 AM ET. CEO Lishan Aklog will provide a business update and CFO Dennis McGrath will discuss Q1 2026 financial results.

Investors can join via webcast at the investor relations page on pavmed.com or by telephone (U.S. 1-800-836-8184; international 1-646-357-8785). A replay will be available on pavmed.com for 30 days after the call.

News Market Reaction – LUCD

+1.87%

+1.87% Session close to close

In the May 1 session, LUCD gained 1.87%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Conference Call and Webcast at 8:30 AM ET

NEW YORK, May 1, 2026 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Friday, May 15, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath, PAVmed's President and Chief Financial Officer, will discuss the Company's first quarter 2026 financial results.

The webcast will be available at the investor relations section of the Company's website at pavmed.com.  Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "PAVmed Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com.

About PAVmed
PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard^® Esophageal DNA Test and EsoCheck^® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer to mitigate the risks of esophageal cancer deaths. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform.

For more information about PAVmed, please visit pavmed.com.

For more information about Lucid Diagnostics, please visit luciddx.com.

For more information about Veris Health, please visit verishealth.com. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pavmed-to-hold-first-quarter-2026-business-update-conference-call-and-webcast-on-may-15-2026-302760042.html

SOURCE PAVmed Inc.

FAQ

When is PAVmed's (LUCD) First Quarter 2026 business update call and webcast?

The call is scheduled for May 15, 2026 at 8:30 AM ET. According to the company, the event will feature a business update from CEO Lishan Aklog and Q1 2026 financial results from CFO Dennis McGrath.

How can investors access the PAVmed (LUCD) May 15, 2026 webcast and conference call?

Investors can join the webcast at the investor relations page on pavmed.com. According to the company, telephone access is available in the U.S. at 1-800-836-8184 and internationally at 1-646-357-8785.

Who will present on the PAVmed (LUCD) May 15, 2026 business update call?

Presenters are Lishan Aklog, CEO, and Dennis McGrath, President and CFO. According to the company, Aklog will discuss operations and strategy while McGrath will discuss the company's first quarter 2026 financial results.

Will PAVmed (LUCD) make a replay of the May 15, 2026 call available and for how long?

Yes; a replay will be available for 30 days after the call on the investor relations page. According to the company, listeners can access the archived webcast at pavmed.com for that period.

What topics will PAVmed (LUCD) cover during the First Quarter 2026 business update?

The call will cover a business update, operations, growth strategy, and Q1 2026 financial results. According to the company, the CEO will discuss strategy while the CFO will review the quarter's financial performance.